Two Zebron GC products win R+D 100 awards
Zebron ZB-Bioethanol column
R+D Magazine has given R+D 100 awards to two of Phenomenex's gas chromatography products - the Zebron ZB-Bioethanol column for biofuel testing and the Zebron ZB-Drug-1 column for analysing narcotics.
The awards, determined by an independent judging panel and the editors of R+D Magazine, recognise the 100 most technologically significant products introduced during the past year.
The Zebron ZB-Bioethanol column meets the biofuel industry's need for fast certification and shipment of product.
It resolves a number of challenges facing bioethanol plants, providing accurate analysis of fuel samples in one-eighth of the time of other columns.
The second winner is the Zebron ZB-Drug-1 column, which quickly and accurately tests for drugs of abuse such as opiates, marijuana and cocaine, in forensic applications and job-applicant screening.
Zebron ZB-Drug-1 successfully eliminates problems associated with analysing biological samples by providing a unique selectivity that resolves target analytes from matrix interferences.
Zebron's proprietary technology provides lower bleed levels than other columns, giving lower detection limits.
Guard Finder is a new interactive online tool for selection of column protection products
Phenomenex has launched Securityguard Ultra, a protection system that extends UHPLC column life and is said to be suitable for virtually any manufacturer's UHPLC, sub-2-micron or core-shell columns.
Phenomenex has launched a Phenyl-Hexyl phase that is claimed to offer a 'unique selectivity' for the separation of compounds that are difficult to resolve using traditional phenyl phases.
Phenomenex has introduced Strata-X-Drug N, its second solid-phase extraction (SPE) sorbent designed for the extraction of drugs of abuse in forensic toxicology.
Phenomenex has announced the publication of a case study, written by scientists at Pfizer, that demonstrates the results of a new method for residual API (active pharmaceutical ingredient) analysis.